Patients With Brain Metastases From HER2-positive Breast Cancer

NCT02135159 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer

Interventions

DRUG: TDM1
RADIATION: Brain Sequential RT

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle